Matrine induces hepatocellular carcinoma apoptosis and represses EMT and stemness through microRNA-299-3p/PGAM1 axis.
BaoLin WangHuiHai WangQin ZhaoFei LuZhenZhuang YanFang ZhouQingLun SuPublished in: Growth factors (Chur, Switzerland) (2022)
This study explored the impacts of matrine on hepatocellular carcinoma (HCC) cell growth, metastasis, epithelial-mesenchymal transition (EMT), and stemness through regulating the microRNA (miR)-299-3p / phosphoglycerate mutase 1 ( PGAM1 ) axis. The association between miR-299-3p expression with the prognosis of HCC patients was studied. miR-299-3p and PGAM1 sequences were transfected into matrine-treated HCC cells, and cell proliferation, invasion, apoptosis, and stemness were detected, as well as protein expression of EMT- and stemness-related makers. The targeting relationship between miR-299-3p and PGAM1 was identified. Matrine elevated miR-299-3p expression, repressed proliferation, invasion, and anti-apoptosis of HCC cells, and constrained EMT and stemness in vitro . PGAM1 was a target of miR-299-3p . Repression of PGAM1 rescued the effects of miR-299-3p downregulation on HCC cells. Matrine stimulates HCC cell apoptosis and represses the process of EMT and stemness through the miR-299-3p / PGAM1 axis.
Keyphrases
- epithelial mesenchymal transition
- cell cycle arrest
- signaling pathway
- induced apoptosis
- pi k akt
- transforming growth factor
- cell death
- cell proliferation
- endoplasmic reticulum stress
- oxidative stress
- stem cells
- poor prognosis
- newly diagnosed
- end stage renal disease
- ejection fraction
- chronic kidney disease
- long non coding rna
- cell cycle
- cell migration
- drug delivery
- prognostic factors
- cancer therapy
- drug induced